Patients with a relapsing course of steroid-responsive encephalopathy associated with autoimmune thyroiditis exhibit persistent intrathecal CD4+ T-cell activation.

Steffen PfeufferTobias RuckLeoni RolfesMatthias Pawlowski Marc Pawlitzki Heinz WiendlStjepana KovacSven Guenther Meuth

Published in: European journal of neurology (2020)

Our findings indicate a potential biomarker for risk stratification in patients with SREAT. Currently, it remains unclear whether the observed two phenotypes are different spectra of SREAT or represent separate diseases in terms of pathophysiology.

Keyphrases

multiple sclerosis
early onset
cancer therapy
density functional theory
disease activity
drug induced
drug delivery